Completed OBSERVATIONAL NCT04176211

The Impact of Myasthenia Gravis in the Real World

Sponsor: Vitaccess Ltd

Updated 12 times since 2019 Last updated: May 30, 2024 Started: Dec 12, 2019 Primary completion: May 31, 2024 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Myasthenia Gravis, this trial is completed. The trial is conducted by Vitaccess Ltd and has accumulated 12 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed

Status: Recruiting → Completed
Nov 2023 — Jul 2024 [monthly]

Recruiting
Jun 2023 — Nov 2023 [monthly]

Recruiting
Nov 2022 — Jun 2023 [monthly]

Recruiting

▶ Show 7 earlier versions

Nov 2021 — Nov 2022 [monthly]

Recruiting
May 2021 — Nov 2021 [monthly]

Recruiting
Apr 2021 — May 2021 [monthly]

Recruiting
Jan 2021 — Apr 2021 [monthly]

Recruiting
Oct 2020 — Jan 2021 [monthly]

Recruiting
Jan 2020 — Oct 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Dec 2019 — Jan 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vitaccess Ltd

Data source: Vitaccess Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oxford, United Kingdom